Marcos Couto

Discovery of Potent EGFR Inhibitors through the Incorporation of a 3D‐Aromatic‐Boron‐Rich‐Cluster into the 4‐Anilinoquinazoline Scaffold: Potential Drugs for Glioma Treatment

Marcos Couto, María Fernanda García, Catalina Alamón et al. · Chemistry - A European Journal · 2017 · 81 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Small‐Molecule Kinase‐Inhibitors‐Loaded Boron Cluster as Hybrid Agents for Glioma‐Cell‐Targeting Therapy

Marcos Couto, Ignacio Mastandrea, Mauricio Cabrera et al. · Chemistry - A European Journal · 2017 · 63 citations

Medicine, Medicinal Chemistry, Oncology +17

Bimodal Therapeutic Agents Against Glioblastoma, One of the Most Lethal Forms of Cancer

Marcos Couto, Catalina Alamón, S. Nievas et al. · Chemistry - A European Journal · 2020 · 58 citations

Medicine, Oncology, Pharmacology +16

Closo-Carboranyl- and Metallacarboranyl [1,2,3]triazolyl-Decorated Lapatinib-Scaffold for Cancer Therapy Combining Tyrosine Kinase Inhibition and Boron Neutron Capture Therapy

Marcos Couto, Catalina Alamón, María Jesús García García et al. · Cells · 2020 · 39 citations · Full text

Medicine, Medicinal Chemistry, Oncology +17

Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-β, Exhibits Powerful In Vivo Anti-Glioblastoma Activity

Catalina Alamón, Belén Dávila, María Fernanda García et al. · Cancers · 2020 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17